Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis
- PMID: 20551060
- DOI: 10.1158/0008-5472.CAN-09-4372
Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis
Abstract
We analyzed the gene expression profiles of clinical lung carcinomas using a cDNA microarray containing 27,648 genes or expressed sequence tags, and identified CDCA5 (cell division cycle associated 5) to be upregulated in the majority of lung cancers. Tumor tissue microarray analysis of 262 non-small cell lung cancer patients revealed that CDCA5 positivity was an independent prognostic factor for lung cancer patients. Suppression of CDCA5 expression with siRNAs inhibited the growth of lung cancer cells; concordantly, induction of exogenous expression of CDCA5 conferred growth-promoting activity in mammalian cells. We also found that extracellular signal-regulated kinase (ERK) kinase phosphorylated CDCA5 at Ser79 and Ser209 in vivo. Exogenous expression of phospho-mimicking CDCA5 protein whose Ser209 residue was replaced with glutamine acid further enhanced the growth of cancer cells. In addition, functional inhibition of the interaction between CDCA5 and ERK kinase by a cell-permeable peptide corresponding to a 20-amino-acid sequence part of CDCA5, which included the Ser209 phosphorylation site by ERK, significantly reduced phosphorylation of CDCA5 and resulted in growth suppression of lung cancer cells. Our data suggest that transactivation of CDCA5 and its phosphorylation at Ser209 by ERK play an important role in lung cancer proliferation, and that the selective suppression of the ERK-CDCA5 pathway could be a promising strategy for cancer therapy.
Copyright 2010 AACR.
Similar articles
-
Phosphorylation and activation of cell division cycle associated 8 by aurora kinase B plays a significant role in human lung carcinogenesis.Cancer Res. 2007 May 1;67(9):4113-22. doi: 10.1158/0008-5472.CAN-06-4705. Cancer Res. 2007. PMID: 17483322
-
FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding.Oncogene. 2010 May 27;29(21):3087-99. doi: 10.1038/onc.2010.69. Epub 2010 Mar 15. Oncogene. 2010. PMID: 20228838
-
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.Cancer Res. 2005 Jul 15;65(14):6275-81. doi: 10.1158/0008-5472.CAN-05-0216. Cancer Res. 2005. PMID: 16024629
-
Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway.J Cell Physiol. 2012 Jan;227(1):35-43. doi: 10.1002/jcp.22722. J Cell Physiol. 2012. PMID: 21412767 Review.
-
ERKs in cancer: friends or foes?Cancer Res. 2014 Jan 15;74(2):412-9. doi: 10.1158/0008-5472.CAN-13-2381. Epub 2014 Jan 9. Cancer Res. 2014. PMID: 24408923 Review.
Cited by
-
Silencing oncogene cell division cycle associated 5 induces apoptosis and G1 phase arrest of non-small cell lung cancer cells via p53-p21 signaling pathway.J Clin Lab Anal. 2022 May;36(5):e24396. doi: 10.1002/jcla.24396. Epub 2022 Apr 4. J Clin Lab Anal. 2022. PMID: 35373420 Free PMC article.
-
Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient.Oncotarget. 2018 Jan 9;9(6):6977-6992. doi: 10.18632/oncotarget.24059. eCollection 2018 Jan 23. Oncotarget. 2018. PMID: 29467944 Free PMC article.
-
Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.PLoS One. 2021 Jun 18;16(6):e0253136. doi: 10.1371/journal.pone.0253136. eCollection 2021. PLoS One. 2021. PMID: 34143800 Free PMC article.
-
AKT3-mediated IWS1 phosphorylation promotes the proliferation of EGFR-mutant lung adenocarcinomas through cell cycle-regulated U2AF2 RNA splicing.Nat Commun. 2021 Jul 30;12(1):4624. doi: 10.1038/s41467-021-24795-1. Nat Commun. 2021. Retraction in: Nat Commun. 2022 Jun 28;13(1):3711. doi: 10.1038/s41467-022-31445-7. PMID: 34330897 Free PMC article. Retracted.
-
Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.Oncol Rep. 2018 Oct;40(4):1875-1884. doi: 10.3892/or.2018.6579. Epub 2018 Jul 17. Oncol Rep. 2018. PMID: 30015982 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous